New
Powering
Orthopedic Care
Naitive's AI platform helps orthopedic providers surface at-risk patients, convert them to treatment, and coordinate their care
Poor bone health is a massive problem in orthopedics
50%
90%
170k
$
Naitive is building across the bone health care pathway, from Image to Intervention
FDA-Cleared
Capture
Our AI-enabled, FDA-cleared technology analyzes X-rays in the background, providing a low friction, evidence backed flag for orthopedic surgeons pre-operatively
Coming Soon
Convert
more patients from referral to treatment
Boosting referral-to-treatment conversion by 20%, enabling more patients to be treated and more reimbursements to be unlocked
Coming Soon
Coordinate
patient care, minimizing admin time and unlocking capacity
Eliminating the hours per week spent setting up referral pathways, tracking patients through the care journey, and generating insurer letters
Our Process
Science-Led, Real Clinical Impact
Our technology is designed to be explainable, reproducible, and seamlessly integrated into the way clinicians work.
Trustworthy AI
Our proprietary image processing pipeline segments the bone and isolates the region most predictive of low bone mineral density, enabling transparent, reproducible results clinicians can trust.
Clinical Rigor
We work with leading institutions in the US to train, test, and validate our AI, ensuring it meets the highest standards of safety and effectiveness before deployment.
X-rays Analyzed
Specificity
Benefits
Benefits of our Bone Health Platform
Driving better outcomes with AI-powered patient identification, trusted referral support, and scalable bone health services
Early Patient Identification
Opportunistic assessment which would normally be missed enabling earlier intervention
Streamlined Referrals
OsteoSight reduces the time clinicians spend eliciting referrals internally by providing clear, trusted results that streamline referral decisions.
Service Growth & Revenue
With more eligible patients identified, practices can expand services, capture ancillary revenue, and build a stronger case for further investment into bone health.